Epidemiology of sarcoidosis in a prospective cohort study of U.S. Women

Annals of the American Thoracic Society

Volumn 13, Issue 1, 2016, Pages 67-71

  Dumas, Orianne ^a,b   Abramovitz, Lisa ^a   Wiley, Aleta S ^a   Cozier, Yvette C ^c   Camargo, Carlos A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BOSTON UNIVERSITY   (United States)

Author keywords

Epidemiology; Incidence; Lung diseases; Prevalence

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MIDDLE AGED; NURSE; PREVALENCE; PROSPECTIVE STUDY; QUESTIONNAIRE; RACE DIFFERENCE; SARCOIDOSIS; SELF REPORT; UNITED STATES; DEMOGRAPHY; NURSING RESEARCH; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SARCOIDOSIS, PULMONARY; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA;

ADULT; COHORT STUDIES; DEMOGRAPHY; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; NURSING RESEARCH; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SARCOIDOSIS; SARCOIDOSIS, PULMONARY; SOCIOECONOMIC FACTORS; SURVEYS AND QUESTIONNAIRES; UNITED STATES;

EID: 84989211347     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201508-568BC     Document Type: Article

References (35)

1. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357:2153-2165.
2. Iannuzzi MC, Fontana JR. Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics. JAMA 2011;305:391-399.
3. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, et al.; Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001;164:1885-1889.
4. Cozier YC, Berman JS, Palmer JR, Boggs DA, Serlin DM, Rosenberg L. Sarcoidosis in black women in the United States: data from the Black Women's Health Study. Chest 2011;139:144-150.
5. Gerke AK. Morbidity and mortality in sarcoidosis. Curr Opin Pulm Med 2014;20:472-478.
6. Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997;145:234-241.
7. Morimoto T, Azuma A, Abe S, Usuki J, Kudoh S, Sugisaki K, Oritsu M, Nukiwa T. Epidemiology of sarcoidosis in Japan. Eur Respir J 2008; 31:372-379.
8. Byg K-E, Milman N, Hansen S. Sarcoidosis in Denmark 1980-1994: a registry-based incidence study comprising 5536 patients. Sarcoidosis Vasc Diffuse Lung Dis 2003;20:46-52.
9. Hillerdal G, Nöu E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis 1984;130:29-32.
10. Nicholson TT, Plant BJ, Henry MT, Bredin CP. Sarcoidosis in Ireland: regional differences in prevalence and mortality from 1996-2005. Sarcoidosis Vasc Diffuse Lung Dis 2010;27:111-120.
11. Cozier YC, Ruiz-Narvaez EA, McKinnon CJ, Berman JS, Rosenberg L, Palmer JR. Fine-mapping in African-American women confirms the importance of the 10p12 locus to sarcoidosis. Genes Immun 2012; 13:573-578.
12. Cozier Y, Ruiz-Narvaez E, McKinnon C, Berman J, Rosenberg L, Palmer J. Replication of genetic loci for sarcoidosis in US black women: data from the Black Women's Health Study. Hum Genet 2013;132:803-810.
13. Cozier YC, Coogan PF, Govender P, Berman JS, Palmer JR, Rosenberg L. Obesity and weight gain in relation to incidence of sarcoidosis in US black women: data from the Black Women's Health Study. Chest 2015;147:1086-1093.
14. Newman LS, Rose CS, Bresnitz EA, Rossman MD, Barnard J, Frederick M, Terrin ML, Weinberger SE, Moller DR, McLennan G, et al.; ACCESS Research Group. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004;170:1324-1330.
15. Kucera GP, Rybicki BA, Kirkey KL, Coon SW, Major ML, Maliarik MJ, Iannuzzi MC. Occupational risk factors for sarcoidosis in African-American siblings. Chest 2003;123:1527-1535.
16. Henke CE, Henke G, Elveback LR, Beard CM, Ballard DJ, Kurland LT. The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival. Am J Epidemiol 1986;123:840-845.
17. Prezant DJ, Dhala A, Goldstein A, Janus D, Ortiz F, Aldrich TK, Kelly KJ. The incidence, prevalence, and severity of sarcoidosis in New York City firefighters. Chest 1999;116:1183-1193.
18. Gorham ED, Garland CF, Garland FC, Kaiser K, Travis WD, Centeno JA. Trends and occupational associations in incidence of hospitalized pulmonary sarcoidosis and other lung diseases in Navy personnel: a 27-year historical prospective study, 1975-2001. Chest 2004;126:1431-1438.
19. Rockhill B, Willett WC, Hunter DJ, Manson JE, Hankinson SE, Spiegelman D, Colditz GA. Physical activity and breast cancer risk in a cohort of young women. J Natl Cancer Inst 1998;90:1155-1160.
20. Camargo CA Jr, Weiss ST, Zhang S, Willett WC, Speizer FE. Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med 1999;159:2582-2588.
21. Mahalingaiah S, Hart JE, Laden F, Aschengrau A, Missmer SA. Air pollution exposures during adulthood and risk of endometriosis in the Nurses' Health Study II. Environ Health Perspect 2014;122:58-64.
22. Herná n MA, Olek MJ, Ascherio A. Geographic variation of MS incidence in two prospective studies of US women. Neurology 1999; 53:1711-1718.
23. Colditz GA, Martin P, Stampfer MJ, Willett WC, Sampson L, Rosner B, Hennekens CH, Speizer FE. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 1986;123:894-900.
24. Judson MA, Thompson BW, Rabin DL, Steimel J, Knattereud GL, Lackland DT, Rose C, Rand CS, Baughman RP, Teirstein AS; ACCESS Research Group. The diagnostic pathway to sarcoidosis. Chest 2003;123:406-412.
25. Sawahata M, Sugiyama Y, Nakamura Y, NakayamaM, Mato N, Yamasawa H, Bando M. Age-related and historical changes in the clinical characteristics of sarcoidosis in Japan. Respir Med 2015;109:272-278.
26. Martusewicz-Boros MM, Boros PW, Wiatr E, Roszkowski-Śliż K. What comorbidities accompany sarcoidosis? A large cohort (n=1779) patients analysis. Sarcoidosis Vasc Diffuse Lung Dis 2015;32:115-120.
27. Judson MA, Boan AD, Lackland DT. The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc Diffuse Lung Dis 2012; 29:119-127.
28. Lenner R, Schilero GJ, Padilla ML, Teirstein AS. Sarcoidosis presenting in patients older than 50 years. Sarcoidosis Vasc Diffuse Lung Dis 2002;19:143-147.
29. Cozier YC, Berman JS, Palmer JR, Boggs DA, Wise LA, Rosenberg L. Reproductive and hormonal factors in relation to incidence of sarcoidosis in US Black women: the Black Women's Health Study. Am J Epidemiol 2012;176:635-641.
30. Coquart N, Cadelis G, Tressie res B, Cordel N. Epidemiology of sarcoidosis in Afro-Caribbean people: a 7-year retrospective study in Guadeloupe. Int J Dermatol 2015;54:188-192.
31. Gribbin J, Hubbard RB, Le Jeune I, Smith CJP, West J, Tata LJ. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 2006;61:980-985.
32. Kurata A. Hygiene hypothesis: why south/north geographical differences in prevalence of asthma and sarcoidosis? Med Hypotheses 2012;79:363-364.
33. Kajdasz DK, Judson MA, Mohr LC Jr, Lackland DT. Geographic variation in sarcoidosis in South Carolina: its relation to socioeconomic status and health care indicators. Am J Epidemiol 1999;150:271-278.
34. Kajdasz DK, Lackland DT, Mohr LC, Judson MA. A current assessment of rurally linked exposures as potential risk factors for sarcoidosis. Ann Epidemiol 2001;11:111-117.
35. Jamilloux Y, Bonnefoy M, Valeyre D, Varron L, Broussolle C, Se ve P. Elderly-onset sarcoidosis: prevalence, clinical course, and treatment. Drugs Aging 2013;30:969-978.